Healthcare


 Bioscience Inc. (VIVO) agrees to US$1.5 Bn buyout deal

Bioscience Inc. (VIVO) agrees to US$1.5 Bn buyout deal

July 09, 2022 12:35 AM AEST | By Mridul Gogoi

Bioscience Inc. (Nasdaq: VIVO) concedes to US$1.5 Bn buyout deal by Seoul-based device maker SD Biosensor Inc. for US$1.53 billion.

 NBIX to ITCI: Five mid-cap healthcare stocks to watch in July

NBIX to ITCI: Five mid-cap healthcare stocks to watch in July

July 05, 2022 06:33 AM AEST | By Versha Jain

Healthcare sector has been in good stead and shown resilience in a bearish market.

 NeuroSense (NRSN) stock soars 35% after Alzheimer's study results

NeuroSense (NRSN) stock soars 35% after Alzheimer's study results

July 01, 2022 02:51 AM AEST | By Versha Jain

NeuroSense stock soared over 35% on Thursday after study results showing potential of its drug combination for Alzheimer's treatment.

 Kezar (KZR) stock soars 49% on positive lupus trial results

Kezar (KZR) stock soars 49% on positive lupus trial results

June 29, 2022 04:31 AM AEST | By Versha Jain

Kezar (KZR) stock soared on the positive top-line data from Mission phase 2 clinical trial.

 Acutus (AFIB) stock zooms 100% after FDA clearance

Acutus (AFIB) stock zooms 100% after FDA clearance

June 28, 2022 02:37 AM AEST | By Versha Jain

Acutus stock jumped on Monday after getting FDA clearance.

 Novartis AG (NVS) stock rises after FDA’s accelerated drug approval

Novartis AG (NVS) stock rises after FDA’s accelerated drug approval

June 24, 2022 02:13 AM AEST | By Versha Jain

Novartis AG received FDA's accelerated approval for the combination of its two drugs, Tafinlar and Mekinist as first tumor-agnostic indication.

 Seagen (SGEN) stock roared 17% higher on Merck’s (MRK) buyout plan

Seagen (SGEN) stock roared 17% higher on Merck’s (MRK) buyout plan

June 18, 2022 04:37 AM AEST | By Versha Jain

Highlights: Washington-based Seagen Inc. (NASDAQ: SGEN) stock rose 16.76% on Friday. Merck & Company, Inc. (MRK) is considering buying the bio...

 Cogent Biosciences (COGT) stock soars 101% on positive trial data

Cogent Biosciences (COGT) stock soars 101% on positive trial data

June 11, 2022 04:45 AM AEST | By Versha Jain

Highlights: Cogent Biosciences, Inc. (NASDAQ: COGT) develops therapies for genetic diseases. The company went public on March 26, 2018.  On...

 Top healthcare stocks to explore in June: JNJ, LLY, ABBV, MRK & BMY

Top healthcare stocks to explore in June: JNJ, LLY, ABBV, MRK & BMY

June 10, 2022 09:38 AM AEST | By Rupam Roy

Highlights: Johnson & Johnson (NYSE: JNJ) revenue increased by 5% YoY in Q1, FY22. Merck & Company, Inc. (NYSE: MRK) revenue rose 50% YoY...

 Becton, Dickinson & Co (BDX) to acquire Parata Systems for US$1.525 bn

Becton, Dickinson & Co (BDX) to acquire Parata Systems for US$1.525...

June 07, 2022 03:08 AM AEST | By Mridul Gogoi

Highlights: Becton, Dickinson & Company or BD (NYSE: BDX) to acquire Parata Systems for US$1.525 billion. The deal is likely to close by the e...

 Turning Point (TPTX) stock zooms 115% on Bristol Myers’ (BMY) acquisition

Turning Point (TPTX) stock zooms 115% on Bristol Myers’ (BMY) acquis...

June 04, 2022 04:31 AM AEST | By Versha Jain

Highlights  Turning Point Therapeutics, Inc. (TPTX) is focused on precision oncology therapy. It was founded in 2013 and launched its IPO in...

 Why Immix Biopharma Inc (IMMX) stock soared 55% on Friday?

Why Immix Biopharma Inc (IMMX) stock soared 55% on Friday?

May 21, 2022 06:21 AM AEST | By Versha Jain

The Immix Biopharma Inc. (NASDAQ: IMMX) stock surged 55% after announcing positive results for its lead drug candidate IMX-110 in the first treatment...

 MCK to ABC: 5 healthcare stocks that returned strong 1-year, YTD gains

MCK to ABC: 5 healthcare stocks that returned strong 1-year, YTD gai...

May 14, 2022 04:40 AM AEST | By Versha Jain

Highlights  Bristol-Myers Squibb (NYSE: BMY) has a P/E ratio of 27.0 and a dividend yield of 2.84%. Merck & Company, Inc.'s (NYSE: MRK) P...

 Biohaven (BHVN) stock soars 70% after Q1 results, Pfizer’s (PFE) buy offer

Biohaven (BHVN) stock soars 70% after Q1 results, Pfizer’s (PFE) buy...

May 11, 2022 04:32 AM AEST | By Versha Jain

Highlights  Drugmaker Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) net product revenue grew 182% YoY to US$123.6 million in the q...

 BioNTech’s (BNTX) Q1 earnings surge on COVID-19 vaccine sales

BioNTech’s (BNTX) Q1 earnings surge on COVID-19 vaccine sales

May 10, 2022 03:06 AM AEST | By Team Kalkine Media

Highlights: BioNTech (BNTX) reported first-quarter FY-2022 revenues of €6.4 billion (US$6.7 billion). The net income for the first quarter of...

 CVS Health reports strong Q1 FY-2022 results to outpace estimates

CVS Health reports strong Q1 FY-2022 results to outpace estimates

May 05, 2022 06:12 AM AEST | By Team Kalkine Media

Highlights: CVS Health Corporation beats Wall Street estimates in Q1 2022 earnings report. CVS reported total revenue of US$76.8 billion in Q1 FY-...

 Pfizer (PFE) posts Q1 revenue of US$25.7bn as Comirnaty vaccine shines

Pfizer (PFE) posts Q1 revenue of US$25.7bn as Comirnaty vaccine shin...

May 04, 2022 06:18 AM AEST | By Team Kalkine Media

Highlights: Pfizer Inc. (NYSE: PFE) reported a strong Q1, FY 2022, revenue of US$25.7 billion on Tuesday. Pfizer posted 82% operational revenue g...

 Why Vaxxinity Inc. (VAXX) stock zoomed over 80% on Friday?

Why Vaxxinity Inc. (VAXX) stock zoomed over 80% on Friday?

April 30, 2022 08:17 AM AEST | By Versha Jain

Highlights Texas-based Vaxxinity is a biotechnology company specializing in vaccines for chronic disorders and infectious diseases. The company la...

 Eli Lilly’s (LLY) Q1 revenue grows 15% on obesity drug sales

Eli Lilly’s (LLY) Q1 revenue grows 15% on obesity drug sales

April 29, 2022 05:21 AM AEST | By Team Kalkine Media

Highlights: Eli Lilly and Company (LLY) reported a 15% revenue growth in the first quarter. Eli Lilly’s Covid-19 vaccine revenue grew to US$...

 Why Evoke Pharma (EVOK) stock soared 139%?

Why Evoke Pharma (EVOK) stock soared 139%?

April 27, 2022 03:56 AM AEST | By Versha Jain

Highlights  Evoke Pharma is a specialty pharmaceutical company focused on drugs for treating gastrointestinal disorders and diseases.  ...

Recent Articles

 Should you buy Nike stock on the post earnings dip?
March 24, 2024 04:12 AM AEDT | By Invezz

 Exploring Solana’s memecoins scene: ATH volumes, unsuccessful transactions, & rug pulls
March 24, 2024 12:41 AM AEDT | By Invezz

 Floki’s new roadmap prioritizes utility: Banking solutions, P2E games, and more
March 23, 2024 10:57 PM AEDT | By Invezz

 Investors await Bitcoin Dogs launch as CEXs eye 0DOG listing
March 23, 2024 08:39 PM AEDT | By Invezz

 Crypto fear and greed index retreats as Algotech token sale spikes
March 23, 2024 06:33 PM AEDT | By Invezz


Top Listed Companies